UA95183C2 - Method for assesment of effectiveness of treatment WITH CILASAPRIL of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
- Google Patents
Method for assesment of effectiveness of treatment WITH CILASAPRIL of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
Государственное Высшее Учебное Заведение "Ужгородский Национальный Университет"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное Высшее Учебное Заведение "Ужгородский Национальный Университет"filedCriticalГосударственное Высшее Учебное Заведение "Ужгородский Национальный Университет"
Priority to UAA201006166ApriorityCriticalpatent/UA95183C2/en
Publication of UA95183C2publicationCriticalpatent/UA95183C2/en
Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow
(AREA)
Abstract
The invention relates to medicine and concerns a method for evaluating the effectiveness of treatment of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type with cysalapril, which provides that before and after treatment with cysalapril in patient at rest the Doppler echocardiography is performed and transmitral blood flow is determined by measuring the rate of early diastolic filling, and by increasing the rate of early diastolic left ventricular filling at 15% or more after treatment, and hemodynamic and antianginal effects result are stated as positive.
UAA201006166A2010-05-212010-05-21Method for assesment of effectiveness of treatment WITH CILASAPRIL of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
UA95183C2
(en)
Method for assesment of effectiveness of treatment WITH CILASAPRIL of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
Method for assesment of effectiveness of treatment WITH CILASAPRIL of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
Method for assesment of effectiveness of treatment WITH CILASAPRIL of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
Method for assesment of effectiveness of treatment WITH CILASAPRIL of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
Method for assesment of effectiveness of treatment WITH VERAPAMIL of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
method for evaluating the effectiveness of treatment with benidipin of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
method for evaluating the effectiveness of treatment with ISRADIPIN of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
method for evaluating the effectiveness of treatment with MANIDIPIN of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
method for evaluating the effectiveness of treatment with MOEXOPRIL of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
method for evaluating the effectiveness of treatment with quinapril of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
method for evaluating the effectiveness of treatment with PERINDOPRIL of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
method for evaluating the effectiveness of treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with diastolic dysfunction of the left ventricle by "hypertrophic" type
method for evaluating the effectiveness of treatment with trimetazidine of patients with ischemic heart disease with angina pectoris and arterial hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
method for evaluating the effectiveness of treatment with clintiazem of patients with ischemia with angina pectoris and arterial hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
method for evaluating the effectiveness of treatment with candesartan of patients with coronary heart disease with angina pectoris and hypertension at disorder of the left ventricular diastolic function by "hypertrophic" type
method for evaluating the effectiveness of treatment with losartan of patients with coronary heart disease with angina pectoris and hypertension at disorder of left ventricular diastolic function by "hypertrophic" type
Method for assessing efficacy of cilasapril treatment in patients with ischemic heart disease, angina and arterial hypertension with impaired diastolic function of left ventricle of 'hypertrophic' type
Method for assessing efficacy of celiprolol treatment in patients with ischemic heart disease, cardiac angina and arterial hypertension with impaired diastolic function of left ventricle of 'hypertrophic' type
Method for assessing efficacy of oxprenolol treatment in patients with ischemic heart disease, cardiac angina and arterial hypertension with impaired diastolic function of left ventricle of 'hypertrophic' type
Evaluation of effectiveness of therapy with pindolol in patients with coronary disease with angina and diastolic dysfunction in left ventricular hypertrophy
Evaluation of effectiveness of therapy with carvedilol in patients with coronary disease with angina and diastolic dysfunction in left ventricular hypertrophy
Evaluation of effectiveness of therapy with quinapril in patients with coronary disease with angina and diastolic dysfunction in left ventricular hypertrophy
Method for the assessment of acebutolol therapy efficiency in patients with coronary disease with cardiac angina and arterial hypertension with left ventricular hypertrophy
Method for the assessment of talinolol therapy efficiency in patients with coronary disease with cardiac angina and hypertensive left ventricular hypertrophy
Method for assessment of fenofibrate efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to "hypertrophic" type
Method for the assessment of labetalol therapy efficiency in patients with coronary disease with cardiac angina and arterial hypertension with left ventricular hypertrophy
Method for assessing efficacy of lovastatin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
Method for assessing efficacy of amlodipin in treatment of ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic type of impairment of diastolic function of left ventricle